Synthesis and HPLC-purification of [77Br]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class

[77Br]TMC125-R165335 (etravirine) was synthesized for imaging studies by SPECT. Labelling was performed with bromine-77 by electrophilic substitution of the desbromo-precursor 4-{6-amino-2-[(4-cyanophenyl)amino]pyrimidin-4-yloxy}-3,5-dimethylbenzenecarbonitrile using carrier-free 77Br− and chloramine-T (CAT) as oxidizing agent. The reaction proceeded in 10 min at room temperature in aqueous DMSO as solvent. Purification was performed by HPLC, giving a chemically and radiochemically pure [77Br]TMC125-R165335 (etravirine) in aqueous ethanol. A final radiolabelling yield of 50% is obtained. Copyright © 2006 John Wiley & Sons, Ltd.

[1]  Rudi Pauwels,et al.  New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections. , 2004, Current opinion in pharmacology.

[2]  Erik De Clercq,et al.  HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches. , 2004 .

[3]  R. Gulick,et al.  New antiretroviral agents for the treatment of HIV infection , 2004, Current HIV/AIDS reports.

[4]  H. M. Vinkers,et al.  Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. , 2004, Journal of medicinal chemistry.

[5]  B. Haslinger,et al.  TMC-125 Tibotec. , 2004, Current opinion in investigational drugs.

[6]  B. Gazzard,et al.  An open-label assessment of TMC 125—a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance , 2003, AIDS.

[7]  G. Weverling,et al.  TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen , 2003, AIDS.

[8]  R. Pauwels,et al.  Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. , 2001, Bioorganic & medicinal chemistry letters.

[9]  Erik De Clercq,et al.  Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future , 2004, Chemistry & biodiversity.

[10]  G. Slegers,et al.  Production and Purification of 77Br Suitable for Labeling Monoclonal Antibodies Used in Tumor Imaging , 1994 .

[11]  A. Nunn,et al.  Target materials for the cyclotron production of carrier-free 77Br , 1975 .